Check out AxoSim CEO Lowry Curley PhD, and Obatala Sciences CEO Trivia Frazier’s, PhD, MBA, op-ed highlighting their experiences growing companies in Southeast Louisiana and how important funding is for the BioDistrict for future growth and success. Nola.com Letters: BioDistrict will […]
Read More
Check out The Tech Tribune’s Q&A piece with our Co-Founder Michael J. Moore, PhD. AxoSim is honored to be featured three years running as one of Tech Tribune’s best start ups in Louisiana. Tell us […]
Read More
AxoSim is excited to announce our CEO Lowry Curley is featured in the Tech Tribune’s Profile of a Founder. The company has also made their list of best start ups in Louisiana for the past […]
Read More
Our CEO Lowry Curley, PhD, had the honor of being quoted in Genetic Engineering and Biotechnology New’s July cover story. The article, written by Priya Kalia, PhD, focuses on expanding boundaries of in vitro testing […]
Read More
January 12, 2021 AxoSim’s Research Scientist Wesley Anderson published a review paper with Springer Nature’s In Vitro Cellular & Developmental Biology – Animal on advances in 3D neuronal microphysiological systems, the technology that powers AxoSim’s […]
Read More
December 10, 2020 We present a nontraditional fabrication technique for the realization of three-dimensional (3D) microelectrode arrays (MEAs) capable of interfacing with 3D cellular networks in vitro. The technology uses cost-effective makerspace microfabrication techniques to fabricate the 3D […]
Read More
February 21. 2020 Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been raised about the possible effects of these drugs on fetal development. Current developmental neurotoxicity (DNT) […]
Read More
July 15, 2020 Organ-on-a-chip devices that mimic in vivo physiology have the potential to identify effects of chemical and drug exposure in early preclinical stages of drug development while relying less heavily on animal models. We designed […]
Read More
September 1, 2018 Growing concern suggests that some chemicals exert (developmental) neurotoxicity (DNT and NT) and are linked to the increase in incidence of autism, attention deficit and hyperactivity disorders. The high cost of routine […]
Read More
March 27, 2015 The use of advanced in vitro testing is a powerful tool to develop predictive cellular assays suitable for improving the high attrition rates of novel pharmaceutical compounds. A microscale, organotypic model of […]
Read More